Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Macrolides in roles beyond antibiotic therapy

M A Pilot1

  • 1Surgical Unit, London Hospital Medical College, UK.

The British Journal of Surgery
|October 1, 1994
PubMed
Summary

Erythromycin, a macrolide antibiotic, stimulates upper gastrointestinal motility, benefiting conditions like gastroparesis. New macrolide analogues show promise in gastrointestinal activity and immunosuppression.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adrenoceptors and colocolonic inhibitory reflex.

Digestive diseases and sciences·2000
Same author

Sensory and autonomic neuropathy in patients with idiopathic slow-transit constipation.

The British journal of surgery·1999
Same author

Pelvic bioelectrical impedance measurements to detect rectal filling.

Physiological measurement·1998
Same author

Selective autonomic and sensory deficits in slow transit constipation.

Journal of the autonomic nervous system·1997
Same author

Electrically stimulated smooth muscle neosphincter.

The British journal of surgery·1997
Same author

Oral erythromycin improves gastrointestinal motility and transit after subtotal but not total gastrectomy for cancer.

The British journal of surgery·1997

Area of Science:

  • Pharmacology
  • Gastroenterology
  • Immunology

Background:

  • Erythromycin and related macrolides are common antibiotics with frequent gastrointestinal side effects.
  • The gastrointestinal effects of erythromycin are complex, involving both stimulation and inhibition of motility.
  • Recent developments include macrolide analogues with targeted gastrointestinal or immunosuppressive effects.

Purpose of the Study:

  • To investigate the direct impact of erythromycin on gastrointestinal motility.
  • To explore the potential therapeutic applications of erythromycin's prokinetic effects.
  • To review novel macrolide derivatives with distinct pharmacological profiles.

Main Methods:

  • Direct observation and measurement of gastrointestinal motility in response to erythromycin administration.
  • Clinical and experimental utilization of erythromycin for conditions involving impaired gastric emptying.
  • Development and assessment of erythromycin analogues for specific activities.

Main Results:

  • Erythromycin stimulates proximal gastrointestinal motility (stomach, duodenum) and accelerates gastric emptying via an antroduodenal coordination mechanism.
  • This prokinetic effect is beneficial for gastroparesis and has been observed to accelerate gallbladder emptying and affect esophageal motility.
  • New macrolide analogues exhibit significant gastrointestinal activity with reduced antibacterial properties, alongside novel immunosuppressive macrolides.

Conclusions:

  • Erythromycin possesses significant prokinetic properties beneficial in managing gastroparesis and related conditions.
  • Macrolide chemistry has advanced to yield analogues with specialized gastrointestinal and immunosuppressive functions.
  • Further research into macrolides offers potential for novel therapeutic strategies beyond antibacterial applications.

Related Experiment Videos